Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus

Digestive Diseases and Sciences

Volumn 42, Issue 9, 1997, Pages 1853-1858

  Fass, Ronnie ^a,b   Yalam, John M ^a   Camargo, Lisa ^a   Johnson, Cindy ^a   Garewal, Harinder S ^a   Sampliner, Richard E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Barrett's esophagus; Gastroesophageal reflux disease; Multipolar electrocoagulation

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHEMORECEPTOR; CHEMOSENSITIVITY; CLINICAL ARTICLE; ELECTROCOAGULATION; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; STOMACH ACID SECRETION; TREATMENT OUTCOME;

ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; CHEMORECEPTORS; COMBINED MODALITY THERAPY; ELECTROCOAGULATION; ESOPHAGITIS, PEPTIC; ESOPHAGUS; FEMALE; HUMANS; HYDROCHLORIC ACID; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; SENSORY THRESHOLDS;

EID: 0030768122     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018850824287     Document Type: Article

References (28)

1. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, et al: Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344:1533-1536, 1994
2. Pera M, Cameron AJ, Trastek VJ, Carpenter HA, et al: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510-513, 1993
3. Gore S, Healey CJ, Sutton R, Eyre-Brook IA, et al: Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 7:632-638, 1993
4. McArdle JE, Lewin KJ, Randall G, Weinstein W: Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 23:479-482, 1992
5. Gossner L, Sroka R, Stolte M, Seitz G, et al: Barrett's esophagus with severe dysplasia and/or superficial cancer: Initial results of photodynamic therapy using 5-aminolaevolinic acid. Gastrointest Oncol 110:A521, 1996
6. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS: Regression of Barrett's esophagus by laser ablation in an antacid environment. Dig Dis Sci 38:365-368, 1993
7. Berenson MM, Johnson TD, Markowitz NR, et al: Restoration of squamous mucosa after ablation of Barrett's esophagus epithelium. Gastroenterology 104:1686-1691, 1993
8. Jones R, Barnham CP, Hardwick R, Shepherd N, et al: Regression of columnar-lined esophagus following KTP laser ablation with acid suppression. Gastroenterology 110:A537, 1996
9. Laukka MA, Wang KK: Initial results using low dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 42:59-63, 1994
10. Wang KK, Geller A, Gutta K, Laukka M, et al: Photodynamic therapy in the treatment of Barrett's esophagus. Gastroenterology 110:A290, 1996
11. Overholt B, Panjehpour M, Tefftellar E, Rose M: Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 39:73-76, 1993
12. Overholt BF, Panhehpour M: Barrett's esophagus: Photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc 42:64-70, 1995
13. Overholt BF, Pannehpour M: Photodynamic therapy for Barrett's esophagus: Clinical update. Am J Gastroenterol 91:1719-1723, 1996
14. Barr H, Shepherd NA, Roberts DJH, Tan WC, et al: Eradication of high grade dysplasia in columnar lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 348:584-585, 1996
15. Sampliner RE, Fennerty MB, Garewal HS: Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results. Gastrointest Endosc 44:523-525, 1996
16. Aronchick CA, Lipshutz WH, Wright SH, DuFrayne FJ, et al: P9 bicap cautery converts Barrett's epithelium to squamous mucosa. Am J Gastroenterol 90:A1554(3), 1995
17. Schlesinger PK: Diminished esophageal acid sensitivity in patients with advanced esophagitis. Gastroenterology 92:A1622, 1987
18. Johnson DA, Winters C, Spurling TJ, et al: Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol 9:23-27, 1987
19. Trimble KC, Pryde A, Heading RC: Lowered esophageal sensory threshold in patients with symptomatic but not excess gastroesophageal reflux disease: Evidence for a spectrum of visceral sensitivity in GORD. Gut 37:7-12, 1995
20. Stein HJ, Hoeft S, DeMeester TR: Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg 105:107-111, 1993
21. Johnson LF, DeMeester TR: Twenty-four hour pH monitoring of the distal esophagus. Am J Gastroenterol 62:325-332, 1974
22. Hetzel DJ, Dent J, Reed WD, Marieluala FM, et al: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903-912, 1988
23. Gracely RH, McGrath P, Dunber R: Ratio scales of sensory and affective verbal pain descriptors. Pain 5:5-18, 1978
24. Smith JL, Opekun AR, Larkai E, Graham DY: Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 96:683-689, 1989
25. Fass R, Higa L, Kodner A, Naliboff B, et al: Chronic mucosal inflammation of the esophagus in gastroesophageal reflux disease (GHRD) is not associated with mechanical hyperalgesia. Gastroenterology 110:A662, 1996
26. Sampliner RE: Ablative therapies for the columnar lined esophagus. Gastroenterol Clin North Am 1997 (in press)
27. Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107:271-293, 1994
28. Campbell JN, Raja SN, Cohen RH, Manning DC, et al: Peripheral neural mechanisms of nociception. In Textbook of Pain. RD Wall, R Melzack (eds). New York, Churchill Livingstone, 1989, pp 22-45